Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alteplase for Blood Flow Restoration in Hemodialysis Catheters
NCT00303420Phase 4Terminated
- Sponsor
- University of Manitoba
- Start
- Sep 2004
- Primary completion
- Dec 2008
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 4, randomised trial of tissue-plasminogen activator in thrombosis (2 arms), sponsored by University of Manitoba. Primary endpoint: Proportion of patients achieving sustainable post thrombolytic blood flow >= 300 ml/min at 4 hours. Started Sep 2004; status: terminated.
02
Drugs
tissue-plasminogen activator
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT00303420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00303420.